Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Gsk4527226's trials
PROGRESS-AD
Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease
GSK4527226
Ongoing
Active not recruiting
Phase 2
Open NCT06079190 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
PROGRESS-AD · Trial Tracker · ComplyRx
